Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.

Kalluri SR, Illes Z, Srivastava R, Cree B, Menge T, Bennett JL, Berthele A, Hemmer B.

Arch Neurol. 2010 Oct;67(10):1201-8. doi: 10.1001/archneurol.2010.269.

PMID:
20937947
2.

Neuromyelitis optica pathogenesis and aquaporin 4.

Graber DJ, Levy M, Kerr D, Wade WF.

J Neuroinflammation. 2008 May 29;5:22. doi: 10.1186/1742-2094-5-22. Review.

3.

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature.

Jarius S, Wildemann B.

Brain Pathol. 2013 Nov;23(6):661-83. doi: 10.1111/bpa.12084. Review.

PMID:
24118483
4.

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).

Asgari N.

Dan Med J. 2013 Oct;60(10):B4730. Review.

PMID:
24083534
5.

[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].

Misu T, Fujihara K, Itoyama Y.

Brain Nerve. 2008 May;60(5):527-37. Review. Japanese.

PMID:
18516975
6.

[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].

Kira J.

Rinsho Shinkeigaku. 2010 Nov;50(11):788-93. Review. Japanese.

PMID:
21921443
7.

[Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].

Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.

Rinsho Byori. 2009 Mar;57(3):262-70. Review. Japanese.

PMID:
19363997
8.

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.

Saikali P, Cayrol R, Vincent T.

Autoimmun Rev. 2009 Dec;9(2):132-5. doi: 10.1016/j.autrev.2009.04.004. Epub 2009 Apr 21. Review.

PMID:
19389490
9.

Neuromyelitis optica.

Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.

Curr Opin Neurol. 2007 Jun;20(3):255-60. Review.

PMID:
17495617
10.

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).

Asgari N, Owens T, Frøkiaer J, Stenager E, Lillevang ST, Kyvik KO.

Acta Neurol Scand. 2011 Jun;123(6):369-84. doi: 10.1111/j.1600-0404.2010.01416.x. Epub 2010 Sep 29. Review.

PMID:
20880299
11.

Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.

Cayrol R, Saikali P, Vincent T.

Ann N Y Acad Sci. 2009 Sep;1173:478-86. doi: 10.1111/j.1749-6632.2009.04871.x. Review.

PMID:
19758189
12.

[Biomarkers in neuromyelitis optica].

Misu T, Takahashi T, Nakashima I, Fujihara K.

Brain Nerve. 2012 May;64(5):525-35. Review. Japanese.

PMID:
22570066
13.

The expanded spectrum of neuromyelitis optica: evidences for a new definition.

Lana-Peixoto MA, Callegaro D.

Arq Neuropsiquiatr. 2012 Oct;70(10):807-13. Review.

14.

Neurological autoimmunity targeting aquaporin-4.

Hinson SR, McKeon A, Lennon VA.

Neuroscience. 2010 Jul 28;168(4):1009-18. doi: 10.1016/j.neuroscience.2009.08.032. Epub 2009 Aug 20. Review.

PMID:
19699271
15.

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.

Nat Clin Pract Neurol. 2008 Apr;4(4):202-14. doi: 10.1038/ncpneuro0764. Epub 2008 Mar 11. Review.

PMID:
18334978
16.

Sjögren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu.

Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA.

Arq Neuropsiquiatr. 2014 Aug;72(8):619-24. Review.

17.

Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.

Verkman AS, Phuan PW, Asavapanumas N, Tradtrantip L.

Brain Pathol. 2013 Nov;23(6):684-95. doi: 10.1111/bpa.12085. Review.

18.

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.

Waters P, Vincent A.

Int MS J. 2008 Sep;15(3):99-105. Review.

PMID:
18808744
19.

Evidence for humoral autoimmunity in neuromyelitis optica.

Wingerchuk DM.

Neurol Res. 2006 Apr;28(3):348-53. Review.

PMID:
16687064
20.

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance.

Jarius S, Wildemann B.

Nat Rev Neurol. 2010 Jul;6(7):383-92. doi: 10.1038/nrneurol.2010.72. Review.

PMID:
20639914

Supplemental Content

Support Center